Delivery Order SPE2DB24D1205-SPE2DB25FCXQE

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,131.12, is for the delivery of ZEPZELCA 4 MG VIALS. It is a firm fixed-price delivery order contract with an ultimate completion date of April 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ZEPZELCA 4 MG VIALS, a pharmaceutical product, with a ceiling value of $9,565.56 and a period of performance through June 25, 2025. The contract is a firm fixed-price arrangement and does not utilize a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization that...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract, valued at $9,025.76, is for the delivery of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,565.56, is for the delivery of ZEPZELCA 4 MG VIALS, a specialty medication. The contract has an ultimate completion date of February 12, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a $18,051.52 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ZEPZELCA 4 MG VIALS, a specialty cancer medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $95,655.40 firm fixed-price delivery order contract is for the provision of ZEPZELCA 4 MG VIALS, a specialty pharmaceutical product. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of ZEPZELCA 4 MG VIALS. The fixed-price, firm-fixed-price contract has a ceiling value of $18,675.40 and an ultimate completion date of January 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of ZEPZELCA 4 MG VIALS. The contract is a Firm Fixed Price type with a ceiling value of $9,025.76 and a period of performance through September 4, 2024. The contract was awarded on August 13, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor for this delivery order. This...
This federal contract award, valued at $9,565.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,104,438 units of the medication ZEPZELCA 4 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The $9,025.76 Firm Fixed Price contract is for the supply of 4,565,122,173 units of the drug ZEPZELCA 4 MG VIALS. This award is part of a larger Indefinite Delivery Contract between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCXQE
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,565.56 contract is for the delivery of 4568517846 ZEPZELCA 4 MG VIALS, with a performance period through July 3, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, particularly the DLA, through both delivery orders and a $999,999,999.00 Indefinite Delivery Contract (IDC). This contract is not designated as a set-aside.

Generated 9/10/25, 9:52 AM